December 18, 2014 1:30 PM ET

Capital Markets

Company Overview of Frazier Healthcare Ventures

Company Overview

Frazier Healthcare Ventures is a private equity and venture capital firm specializing in growth equity financing; incubation; expansion stage equity; recapitalizations; leveraged recapitalizations; buyouts; spinouts; shareholder liquidity; startups, early stage investments including seed and Series A and B financing rounds; late stage investments including Series C, D, mid venture, middle market, bridge financing, and PIPEs investments; and de novo investments across all stages of a company’s development. It seeks to invest in the biopharmaceutical, biotechnology, medical device, medical products, medical supplies, technology-enabled services, and healthcare service sectors. The firm seeks t...

Two Union Square

601 Union Street

Suite 3200

Seattle, WA 98101

United States

Founded in 1991





Key Executives for Frazier Healthcare Ventures

Managing Partner and Founder
Age: 63
Chief Financial Officer and Partner
General Partner
Age: 48
General Partner
Age: 44
General Partner
Compensation as of Fiscal Year 2014.

Frazier Healthcare Ventures Key Developments

Frazier Healthcare Appoints David Socks as Venture Partner

Frazier Healthcare announced that David Socks has joined the Frazier Life Sciences team as a Venture Partner to lead the firm's life sciences company creation efforts. Prior to joining Frazier, Mr. Socks co-founded Incline Therapeutics in 2010 and served as its President and Chief Operating Officer. He previously co-founded Cadence Pharmaceuticals in 2004 and served as its Senior Vice President, Corporate Development and Strategy.

Frazier Healthcare Ventures Presents at 12th Annual BIO Investor Forum, Oct-08-2013

Frazier Healthcare Ventures Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Frazier Healthcare Announces Executive Appointments

Frazier Healthcare announced the closing of its seventh healthcare fund, Frazier Healthcare VII (FH VII). FH VII surpassed its target of $300 million with commitments of $377 million. FH VII investors are comprised of corporate and public pension plans, foundations, endowments, and fund of funds. In conjunction with Frazier Healthcare VII's closing, Brian Morfitt will be promoted to General Partner and Ben Magnano will be promoted to Partner. Brian joined Frazier in 2003 from Summit Partners and Ben joined Frazier in 2006 from Morgan Stanley Venture Partners. Both individuals have contributed significantly to the formation and success of several growth buyout investments. In addition, Dan Estes will be promoted to Vice President. Dan joined Frazier in 2011 from McKinsey & Company and is a member of Frazier's Biopharma team. He has been instrumental with assisting in the review and investment of several portfolio companies such as Semnur Pharmaceutical and Atterocor where he is a board observer.

Similar Private Companies By Industry

Company Name Region
Scott Balice Strategies, LLC United States
Delafield Hambrecht, Inc., Advisory Arm United States
WW Funding Corp. United States
Carter Securities, LLC United States
Alternative Strategy Advisers, LLC United States

Recent Private Companies Transactions

Private Placement
October 30, 2014
Imago BioSciences, Inc.
Private Placement
October 29, 2014
Allena Pharmaceuticals, Inc.
September 23, 2014
PatientKeeper, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Frazier Healthcare Ventures, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at